The key advance in our study is that weshow that Akt signaling supports the maintenance of sarcoma CSC phenotypes such asself-renewal50, and chemo- or radiotherapy resistance and itsactivation in human sarcomas, as well as the correlation of that activation withexpression of CD133 and Nanog. This evidence concerns the gene AKT1 and sarcoma.